Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News JOHNSON & JOHNSON JNJ

Healthcare

Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company's primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including... see more

Add To Watchlist

Recent & Breaking News (NYSE:JNJ)

Johnson & Johnson Announces $10 Billion Share Repurchase Program

PR Newswire October 13, 2015

Johnson & Johnson Announces Start of Clinical Trial of Ebola Vaccine Regimen in Sierra Leone

PR Newswire October 9, 2015

Johnson & Johnson Announces Completion of Cordis Divestiture to Cardinal Health

PR Newswire October 4, 2015

Johnson & Johnson Consumer Inc. Announces Completion of the Divestiture of SPLENDA® Brand to Heartland Food Products Group

PR Newswire September 25, 2015

Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

PR Newswire September 15, 2015

Johnson & Johnson to Participate in the 2015 Morgan Stanley Healthcare Conference

PR Newswire September 3, 2015

Johnson & Johnson to Participate in the 2015 Wells Fargo 10th Annual Healthcare Conference

PR Newswire August 27, 2015

Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2015

PR Newswire July 20, 2015

Johnson & Johnson (JNJ) Q2 profit beats expectations

Canadian Press July 14, 2015

Johnson & Johnson Reports 2015 Second-Quarter Results:

PR Newswire July 14, 2015

Bert Vogelstein, M.D., Wins 2015 Dr. Paul Janssen Award for Biomedical Research

PR Newswire June 17, 2015

Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results

PR Newswire June 16, 2015

CEO and Director of Huntsman Cancer Institute Dr. Mary Beckerle Joins Johnson & Johnson Board of Directors

PR Newswire June 9, 2015

Johnson & Johnson Announces Acceptance of Binding Offer From Cardinal Health To Acquire Cordis

PR Newswire May 28, 2015

Johnson & Johnson to Participate in the Goldman Sachs 36th Annual Global Healthcare Conference

PR Newswire May 27, 2015

China Diabetes Management Devices Market Growth to be Driven by Rise in Sedentary Lifestyle and Life Expectancy and Patient Compliant Technologies Especially for Insulin Pump and CGM

PR Newswire May 20, 2015

Johnson & Johnson seeks to boost drug profits with slew of product submissions

Canadian Press May 20, 2015

Johnson & Johnson Pharmaceutical Segment to Continue Driving Above-Industry Growth with Plans to File More than 10 New Products by 2019, Each with Potential to Exceed $1 Billion in Revenue

PR Newswire May 20, 2015

Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines

PR Newswire May 7, 2015

Johnson & Johnson to Participate in the 2015 Deutsche Bank 40th Annual Health Care Conference

PR Newswire April 30, 2015